fig6

Figure 6. Kaplan-Meier estimates of
progression-free survival (ribociclib + letrozole vs placebo + letrozole) by
geographical region9. Adapted from: Yap YS, et al. ESMO Asia 2016. Abstract LBA1.

Figure 6. Kaplan-Meier estimates of progression-free survival (ribociclib + letrozole vs placebo + letrozole) by
geographical region9. Adapted from: Yap YS, et al. ESMO Asia 2016. Abstract LBA1.